What is Dorzolamide ophthalmic?

Category: Prescription Drugs

Most popular types: Trusopt


Dorzolamide ophthalmic is an antiglaucoma ophthalmic agent and a carbonic anhydrase inhibitor. It is used for the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 0
None 1

Commonly reported side effects and conditions associated with Dorzolamide ophthalmic

Side effect Patients


Based on patients currently taking Dorzolamide ophthalmic

Dosage Patients
2 g twice daily 1
4 g daily 1
6 g daily 1

Why patients stopped taking Dorzolamide ophthalmic

Multiple reasons could be selected

Reason Patients
Other 1
See 1 patient who's stopped taking Dorzolamide ophthalmic


Currently taking Dorzolamide ophthalmic

Duration Patients
2 - 5 years 2
5 - 10 years 1

Stopped taking Dorzolamide ophthalmic

Duration Patients
1 - 6 months 1
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 0
Last updated:
There are no evaluations for Dorzolamide ophthalmic.